Liu Y - Search Results

1

GADD45 proteins: roles in cellular senescence and tumor development.

Zhang L, Yang Z, Liu Y. Zhang L, et al. Among authors: liu y. Exp Biol Med (Maywood). 2014 Jul;239(7):773-778. doi: 10.1177/1535370214531879. Epub 2014 May 28. Exp Biol Med (Maywood). 2014. PMID: 24872428

2

Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.

Yang Z, Zhang L, Ma A, Liu L, Li J, Gu J, Liu Y. Yang Z, et al. Among authors: liu y, liu l. PLoS One. 2011;6(12):e28405. doi: 10.1371/journal.pone.0028405. Epub 2011 Dec 1. PLoS One. 2011. PMID: 22145042 Free PMC article.

3

c-MYC overexpression overrides TAK1 dependency in efficient tumorigenicity of AKT-transformed cells.

Qu Y, Zhang L, Ma A, Zhang F, Li J, Xu D, Yang Z, Qin W, Liu Y. Qu Y, et al. Among authors: liu y. Cancer Lett. 2013 Aug 19;336(2):290-8. doi: 10.1016/j.canlet.2013.03.014. Epub 2013 Mar 21. Cancer Lett. 2013. PMID: 23523871

4

Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice.

Li J, Liu Y, Wang B, Xu Y, Ma A, Zhang F, Ge C, Yang Z, Li J, Liu Y. Li J, et al. Among authors: liu y. Carcinogenesis. 2013 Sep;34(9):2099-108. doi: 10.1093/carcin/bgt172. Epub 2013 May 21. Carcinogenesis. 2013. PMID: 23695722

5

Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.

Zhang L, Yang Z, Ma A, Qu Y, Xia S, Xu D, Ge C, Qiu B, Xia Q, Li J, Liu Y. Zhang L, et al. Among authors: liu y. Hepatology. 2014 Jan;59(1):178-89. doi: 10.1002/hep.26628. Epub 2013 Nov 18. Hepatology. 2014. PMID: 23897841

6

Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.

Liu L, Yang Z, Xu Y, Li J, Xu D, Zhang L, Sun J, Xia S, Zou F, Liu Y. Liu L, et al. Among authors: liu y. PLoS One. 2013 Aug 30;8(8):e73038. doi: 10.1371/journal.pone.0073038. eCollection 2013. PLoS One. 2013. PMID: 24023668 Free PMC article.

7

KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.

Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia S, Wang Y, Liu Y, Shi G. Shen P, et al. Among authors: liu y. Prostate. 2014 Jun;74(9):946-58. doi: 10.1002/pros.22812. Epub 2014 Apr 16. Prostate. 2014. PMID: 24737412

8

The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.

Wang Y, Tan H, Xu D, Ma A, Zhang L, Sun J, Yang Z, Liu Y, Shi G. Wang Y, et al. Among authors: liu y. Int J Mol Med. 2014 Jul;34(1):262-8. doi: 10.3892/ijmm.2014.1774. Epub 2014 May 8. Int J Mol Med. 2014. PMID: 24820432

9

Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.

Sun J, Wang B, Liu Y, Zhang L, Ma A, Yang Z, Ji Y, Liu Y. Sun J, et al. Among authors: liu y. Cancer Lett. 2014 Dec 1;355(1):25-33. doi: 10.1016/j.canlet.2014.09.022. Epub 2014 Sep 19. Cancer Lett. 2014. PMID: 25242357

10

SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.

Xu G, Zhang L, Ma A, Qian Y, Ding Q, Liu Y, Wang B, Yang Z, Liu Y. Xu G, et al. Among authors: liu y. Oncotarget. 2015 Oct 20;6(32):33636-47. doi: 10.18632/oncotarget.5602. Oncotarget. 2015. PMID: 26378039 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,486 results

Search Page

Filters